trending Market Intelligence /marketintelligence/en/news-insights/trending/RnwD3OXXAGTSW0cjAYD9XQ2 content esgSubNav
In This List

Permira-backed Corin to buy Omni Orthopaedics


Banking Essentials Newsletter: September Edition, Part - 2


S&P Capital IQ Pro | Unrivaled Sector Coverage


S&P Capital IQ Pro | Powering Your Edge


Street Talk Episode 81: Amid strong recovery, Banc of California hearing more M&A chatter

Permira-backed Corin to buy Omni Orthopaedics

Corin Group PLC entered into a binding agreement to buy Omni Orthopaedics Inc. in a transaction that is set to close by early March.

Corin is a U.K.-based orthopedic company backed by global investment firm Permira. Omni is a U.S.-based designer, developer and manufacturer of medical devices for the orthopedic industry, with expertise in robotic-assisted knee replacement.

KPMG LLP provided financial and tax advice to Corin, while Barclays Bank PLC provided strategic advice and Skadden Arps Slate Meagher & Flom LLP provided legal advice. Piper Jaffray & Co. was Omni's financial adviser, while Foley Hoag LLP was its legal adviser.